As stated in the World Health Organization's statement, these syrups were manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals, and Shape Pharma. The substance diethylene glycol, which can lead to death, was identified in all three medications.
India's Central Drugs Standard Control Organization (CDSCO) informed the WHO in early October. It was also reported that children who took COLDRIF, Respifresh TR, and ReLife syrups were observed to have kidney damage, and at least 22 children died.
The government immediately ordered the production of these medications to be stopped. According to CDSCO information, the toxic syrups were not exported, and no illegal cases regarding this have been identified so far.
The WHO called on all countries to strictly control the Indian drug market and to carefully assess the risks of oral liquid medications.
We remind you that the "Doc-1 Max" syrup, previously manufactured in India, caused the deaths of hundreds of children in Uzbekistan and other countries. The pharmaceutical specialists responsible for that case were sentenced to long-term imprisonment.
